By Aveluro Research Team · Editorial policy
DTG (DTG) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 18,000 VND, little changed on the session, giving a market capitalization of 148.9 billion VND.
On valuation, DTG trades at a price-to-earnings ratio of 5.9 and a price-to-book of 0.7. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 11.9% points to modest profitability relative to the company's equity base, above the sector average of 10.4%. Trailing earnings per share stand at 2,623 VND.
Aveluro tracks 1 news item mentioning DTG, where recent coverage skews positive (100% of articles). The most recent catalyst was an earnings beat smallcap event — "Tipharco (DTG) Q2 2026 Net Profit Surges 24x to VND 7B on Margin Improvement". Aveluro's composite model rates DTG 10.0/10 (Strong Buy), blending news sentiment, price momentum, and fundamentals.
Average daily volume over the past 10 sessions is roughly 4,200 shares; liquidity is relatively thin, so single headlines can move the price sharply. Comparable names in the Health Care sector include AGP, AMV and APC.
What matters now
Tipharco (DTG) Q2 2026 Net Profit Surges 24x to VND 7B on Margin Improvement
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.